News – Page 902 – Endpoints News

Scott Gottlieb has a new board position to add to the resume — and this one is focused on a favorite subject

6 years ago

AstraZeneca's diabetes drug granted fast track designation for heart failure; Verrica sends skin infection treatment ...

6 years ago

BenevolentAI's latest financing could halve its $2B valuation — and that has Woodford watchers worried

6 years ago

Seattle Genetics/Astellas win priority US review for armed antibody aimed at bladder cancer

6 years ago

Karyopharm lines up $150 million cash injection to back controversial drug launch

6 years ago

After a run of CTLA-4 combo failures, scientists spotlight a way to make it work — in select patients

6 years ago

Purdue Pharma files for bankruptcy as first step in $10B opioid settlement

6 years ago

EMA, FDA begin reviewing heartburn medicines for carcinogen

6 years ago

Celgene's AML drug clears late-stage test

6 years ago

Deborah Dunsire is paying $2B for a chance to leap directly into a blockbuster showdown with a few of the world's ...

6 years ago

It's not perfect, but it's a good start: FDA panelists largely endorse Aimmune's peanut allergy therapy

6 years ago

Woodford forced to write down values of holdings; Novartis showcases positive PhIII MS data

6 years ago

Ritter bombs final PhIII for sole lactose intolerance drug — shares plummet

6 years ago

Early snapshot of Adverum's eye gene therapy sparks concern about vision loss

6 years ago

Alex Arfaei trades his analyst's post for a new role as biotech VC; Sanofi vet heads to Vifor

6 years ago

Ardelyx bags its first FDA OK for IBS, setting up a showdown with Allergan, Ironwood

6 years ago

It’s finally over: Biogen, Eisai scrap big Alzheimer’s PhIIIs after a predictable BACE catastrophe raises safety ...

6 years ago

Vertex deal for Scotland — no deal for England

6 years ago

Star founders, investigators huddle around new Boston accelerator spotlighting young entrepreneurs

6 years ago

From partner to knight in shining armor: Castle Creek to buy Fibrocell

6 years ago

Chalk up a big win for Bain as SpringWorks IPO tops out at $162M

6 years ago

Another pharma giant makes a leap into the global medical marijuana business

6 years ago

FDA slaps a hold on one of Amgen’s early-stage cancer drugs, raising cardiac tox concerns for a top prospect in the ...

6 years ago

Bayer trims 2 top execs, shrinks management board; SpringWorks boosts size of IPO

6 years ago

First page Previous page 899 900 901902903 904 905 Next page Last page